Hubbry Logo
PallorPallorMain
Open search
Pallor
Community hub
Pallor
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Pallor
Pallor
Pallor
View on Wikipedia
from Wikipedia
Pallor
Young girl with circumoral pallor as a result of scarlet fever
A girl with circumoral pallor due to scarlet fever
SpecialtyHematology, Rheumatology, Dermatology
Differential diagnosisHypopigmentation

Pallor is a pale color of the skin that can be caused by illness, emotional shock or stress, stimulant use, or anemia, and is the result of a reduced amount of oxyhaemoglobin and may also be visible as pallor of the conjunctivae of the eyes on physical examination.

Pallor is more evident on the face and palms. It can develop suddenly or gradually, depending on the cause. It is not usually clinically significant unless it is accompanied by a general pallor (pale lips, tongue, palms, mouth and other regions with mucous membranes). It is distinguished from similar presentations such as hypopigmentation (lack or loss of skin pigment) or simply a lightly-melanated complexion.

Causes

[edit]
Effects of different skin tone on the appearance of pallor
Portrait of Richard Parkes Bonington by Margaret Sarah Carpenter. Bonington was suffering from tuberculosis and the paleness of his face was noted by critics.

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Pallor

View on Grokipedia
from Grokipedia
Pallor is an abnormal paleness or loss of normal color in the skin or mucous membranes, such as those in the or eyes, often indicating reduced flow to these areas or a decreased number of cells rather than a loss of . This condition can be generalized, affecting the entire body, or localized to a specific area like a limb, and it is typically temporary and reversible once the underlying cause is addressed. Pallor is most noticeable on the face, (the lining of the eyelids), , nail beds, and palms, though it may be harder to detect in individuals with darker tones, where examination of mucous membranes is preferred. The primary causes of pallor include , a condition characterized by insufficient red blood cells or , which reduces oxygen delivery to tissues and is responsible for pallor in many cases. Other causes involve decreased blood supply due to circulatory issues, such as shock, low (), or from cold exposure or emotional stress like . Additional factors can include nutritional deficiencies (e.g., iron, , or ), chronic illnesses affecting blood production like myelodysplastic syndromes, medication side effects, or acute events such as blood loss from injury or hemorrhage. Clinically, pallor serves as an important physical sign for diagnosing underlying conditions, particularly , with being a useful indicator for further testing. typically involves a thorough , focusing on sites like the and palms, and laboratory tests such as a to assess levels. In severe or sudden-onset pallor, especially when accompanied by symptoms like , , rapid heart rate, or , immediate medical evaluation is essential to rule out life-threatening issues like acute loss or shock. Treatment focuses on addressing the root cause, which may involve dietary improvements, supplementation, transfusions, or interventions for circulatory problems.

Overview

Definition

Pallor is defined as an abnormal paleness of the skin, mucous membranes, or nail beds, resulting from a reduction in oxyhemoglobin within the superficial vasculature. This condition reflects a perceptible decrease in the reddish hue (rubor) normally imparted by oxygenated blood in these areas. The skin's coloration is primarily due to oxyhemoglobin in the dermal capillaries, and pallor arises when this is diminished relative to an individual's baseline. Unlike pallor, physiologic paleness represents normal variations and does not signify . For instance, individuals with fair tones may naturally exhibit lighter complexions, while transient paleness can occur from non-pathologic factors such as cold exposure, which causes without compromising overall health. Distinguishing these requires consideration of the individual's typical appearance and context, as pallor is assessed against what is expected for a specific race or . The term "pallor" originates from the Latin pallor, meaning paleness or lack of color, derived from the verb pallere, "to be pale." In medical literature, it has been employed since at least the to describe clinical signs, including those associated with , prior to the quantitative definition of such conditions in the .

Physiology

The normal color of human skin is primarily determined by the interplay of three key pigments: , , and oxyhemoglobin. Melanin, produced by melanocytes, contributes brown to black tones and protects against ultraviolet radiation, while , derived from dietary sources, imparts subtle yellow-orange hues particularly in areas like the palms and soles. Oxyhemoglobin, the oxygenated form of in red blood cells, provides the characteristic red-pink coloration visible through the translucent , as it absorbs certain wavelengths of light in the dermal capillaries. Pallor, or abnormal paleness, results from a reduction in oxyhemoglobin concentration within the skin or diminished blood flow through the superficial capillaries, altering the balance of these pigments and decreasing the red hue. A primary physiological mechanism involves vasoconstriction of the dermal vasculature, triggered by sympathetic nervous system activation via α-adrenergic receptors, which decreases blood volume in the capillary loops and arteriovenous anastomoses. This response, often elicited by cold stress or emotional stimuli, conserves core body heat by redirecting blood to vital organs but visibly reduces the red coloration of the skin. Hemoglobin plays a central role in this process, as oxyhemoglobin's bright red appearance dominates tone under normal oxygenation, whereas deoxygenated lends a darker, bluish tint; however, low total levels diminish overall color intensity regardless of oxygenation state. Conditions like , which reduce circulating red cells, exemplify this by lowering oxyhemoglobin availability and causing pallor. Adequate tissue is essential for maintaining these colors, requiring balanced arterial inflow to supply oxygenated and venous drainage to remove deoxygenated and metabolic byproducts from the 's . Disruptions in either arterial supply or venous return impair this , leading to localized or generalized pallor as oxygenated fails to reach the dermal layers sufficiently.

Clinical Features

Appearance and Assessment

Pallor manifests as an abnormal paleness of the and mucous membranes, most readily observed in regions with thin or high vascularity, such as the face, palms, and . Clinicians assess visible pallor by inspecting these areas and comparing them to the patient's known baseline skin tone or contralateral unaffected sites to detect subtle changes. For instance, the lower palpebral conjunctiva is examined by everting the , where pallor appears as a uniform pale or whitish discoloration of the anterior and posterior rims. Pale conjunctiva, particularly on the inner surface of the lower eyelid (palpebral conjunctiva), is a recognized clinical sign of anemia, indicating low hemoglobin levels and reduced oxygenation. A red and inflamed eyelid is not a typical sign of anemia; it more commonly suggests conditions like blepharitis, stye, allergic reaction, or infection. Tactile evaluation complements , particularly in acute presentations, where the skin may feel cool and clammy due to peripheral and reduced . A blanching test, performed by applying firm to the skin or nail bed for several seconds, can reveal underlying vascular status; in cases of pallor from hypoperfusion, the blanched area exhibits prolonged whiteness upon release, with exceeding 3 seconds indicating impaired circulation. This method helps differentiate pallor from other color changes but requires comparison to normal refill times. In patients with darker skin tones, pallor may not present as obvious whiteness but rather as an ashen gray hue, dullness, or loss of the usual rosy undertone, necessitating targeted inspection of less pigmented areas like the palms, oral mucosa, or conjunctivae for accurate detection. Failure to account for these variations can lead to underdiagnosis in diverse populations. Pallor severity is often graded on a scale from mild to severe based on the extent of involvement. Mild pallor is typically confined to the face or conjunctivae, moderate pallor extends to the palms and trunk, and severe pallor is generalized, including other mucous membranes and nail beds, with pallor showing high diagnostic reliability for profound . These grades guide urgency in clinical evaluation, though interobserver agreement varies.

Associated Symptoms

Pallor is frequently accompanied by , , and , particularly in chronic conditions such as , where reduced oxygen-carrying capacity in the leads to diminished tissue and levels. These symptoms often intensify with physical exertion, reflecting the body's compensatory efforts to maintain adequate oxygenation. In acute scenarios involving hypoperfusion, such as circulatory shock, pallor may occur alongside , syncope, or a rapid heartbeat, signaling inadequate blood flow to vital organs and potential cardiovascular instability. These manifestations underscore the urgency of the condition, as they indicate systemic hypoperfusion that can progress to if untreated. Vasospastic conditions can present with pallor accompanied by cold intolerance or Raynaud's-like phenomena, where episodic causes localized blanching, numbness, and sensitivity to cold temperatures. Such symptoms highlight the role of vascular reactivity in pallor's presentation, often exacerbated by environmental triggers. Systemic signs associated with pallor include in hemolytic processes, where rapid breakdown leads to both paleness from and yellowish discoloration from accumulation. may accompany pallor in heart failure-related cases, resulting from fluid retention and reduced that impairs peripheral circulation. Additionally, fever can co-occur with pallor in infectious etiologies, as systemic inflammation or contributes to both and febrile responses.

Causes

Hematological Causes

Hematological causes of pallor primarily arise from abnormalities in blood composition, most notably , which reduces the oxygen-carrying capacity of the blood and leads to paler skin and mucous membranes. is defined as a reduction in concentration, , or count below normal levels, resulting in decreased oxyhemoglobin that imparts the characteristic red hue to tissues; when falls below approximately 9 g/dL, visible pallor becomes evident due to diminished tissue oxygenation and compensatory . This pallor can manifest acutely in rapid blood loss scenarios, causing sudden paleness, or chronically in progressive conditions, where the body may partially adapt through increased cardiac output, though skin pallor persists as a key sign. The most common type of anemia causing pallor is , which develops from chronic blood loss (e.g., menstrual bleeding or gastrointestinal hemorrhage) or inadequate dietary absorption, leading to microcytic, hypochromic s and reduced synthesis. Other nutritional anemias include megaloblastic types due to or , often from or poor intake, resulting in large, immature s and ineffective that exacerbates pallor. Hemolytic anemias, such as , involve accelerated destruction, leading to and episodic pallor during crises, while stems from failure, causing severe with profound pallor from near-total aplasia. Genetic hemoglobinopathies like , prevalent in Mediterranean populations where carrier rates can reach 1-16% in areas such as and , produce through impaired globin chain synthesis, contributing to chronic pallor. Globally, anemia affected approximately 24.3% of the population, or about 1.92 billion people as of , with higher prevalence in women of reproductive age (30%) and children under five (around 40%), driven largely by nutritional deficiencies and infections. accounts for roughly half of all cases worldwide, underscoring its role as the leading hematological contributor to pallor. Beyond anemia, non-anemic hematological disorders such as acute leukemia or bone marrow suppression from chemotherapy or toxins can induce pallor through pancytopenia, where infiltration or failure of the marrow reduces all blood cell lines, including red blood cells, leading to severe anemia-like pallor alongside fatigue and bleeding tendencies.

Circulatory and Hypoperfusion Causes

Pallor arising from circulatory and hypoperfusion causes results from inadequate blood flow to the skin and peripheral tissues, often due to reduced cardiac output, vascular narrowing, or obstruction, leading to decreased oxygen delivery and visible paleness. In these scenarios, the skin appears pale because of compensatory mechanisms like vasoconstriction that prioritize vital organ perfusion over cutaneous blood supply. Shock states represent a primary category of circulatory causes, where systemic hypoperfusion manifests as generalized . , commonly triggered by hemorrhage, reduces intravascular volume, impairing and prompting intense peripheral that causes pallor, often accompanied by . , stemming from or , diminishes pump efficiency, resulting in low-output hypoperfusion and pallor due to inadequate tissue oxygenation. , such as in , initially may present with but progresses to hypoperfusion in later stages, where compensatory contributes to pallor as oxygen distribution to tissues falters. Vasoconstriction independent of shock can also induce pallor through alpha-adrenergic activation, narrowing cutaneous vessels to redirect flow. Exposure to stimulates sympathetic responses, causing transient pallor in extremities as flow decreases to conserve . Similarly, emotional or acute triggers sympathetic discharge, leading to widespread cutaneous and observable pallor. Vascular diseases often produce localized pallor by compromising regional . Peripheral artery disease (PAD) narrows arteries via , reducing limb blood flow and resulting in pallor, particularly evident during elevation of the affected limb. , causing acute limb ischemia, abruptly occludes vessels, manifesting as sudden pallor alongside pain and pulselessness in the distal extremity. The onset of pallor in these circulatory issues varies by acuity. Acute events, like hemorrhage or , produce rapid pallor due to immediate hypoperfusion. In contrast, chronic conditions such as lead to gradual pallor from sustained low and persistent .

Other Causes

Pallor can arise from emotional and physiological triggers that induce transient , reducing blood flow to the skin. Stress and anxiety activate the , leading to peripheral and subsequent paleness as a visible sign of the . Similarly, syncope, particularly vasovagal syncope, often presents with pallor due to sudden and , which diminish cutaneous ; this is a hallmark prodromal symptom alongside diaphoresis and . Environmental factors such as extreme cold exposure can cause pallor through peripheral aimed at preserving core body temperature. In , defined as a core temperature below 35°C, patients exhibit pale, dry as part of the body's thermoregulatory response, often accompanied by and in mild cases. , a localized freezing , results in white or pale, waxy in the affected areas due to ice crystal formation and vascular shutdown, progressing from numbness to potential blistering upon rewarming. Iatrogenic causes include certain medications that induce or vascular effects leading to pallor. Beta-blockers, by blocking adrenergic receptors, can exacerbate Raynaud's phenomenon, causing episodic digital pallor from vasospasm. Chemotherapy agents such as , , and similarly trigger secondary Raynaud's or direct vascular toxicity, manifesting as pale, cold extremities during treatment cycles. Endocrine and metabolic disorders contribute to pallor by altering metabolic rate, , or sympathetic responses. reduces basal metabolic demand and impairs , resulting in pale, dry, cool skin due to decreased cutaneous blood flow and accumulation of mucopolysaccharides in the . , often from insulin excess or , elicits pallor through adrenergic activation, causing diaphoresis and faded skin color as early autonomic symptoms. Rare causes encompass genetic and nutritional conditions that produce pallor-like appearances independent of anemia. Severe malnutrition can contribute to pallor through associated anemia, dehydration, or other blood volume reductions.

Diagnosis

History and Physical Examination

The history and physical examination serve as the initial diagnostic steps in evaluating pallor, providing essential clues to differentiate between acute and chronic causes such as anemia or hypoperfusion. A thorough patient interview begins by determining the onset and duration of pallor; acute onset often signals rapid blood loss or circulatory compromise, while gradual progression suggests chronic conditions like nutritional deficiencies. Associated symptoms are systematically explored, including fatigue, dizziness, bleeding (e.g., epistaxis or hematuria), exertional dyspnea, or fever, which may point to underlying infection, malignancy, or hemolysis. Risk factors are elicited through questions on diet (e.g., vegetarianism or pica suggesting iron deficiency), medications (e.g., nonsteroidal anti-inflammatory drugs causing gastrointestinal blood loss), family history of hereditary anemias, and recent exposures like trauma or infections that could precipitate shock. To build a targeted differential, history-taking is tailored to suspected etiologies; for example, detailed menstrual or obstetric history in females helps identify chronic blood loss leading to , whereas inquiries into recent trauma, surgery, or raise suspicion for . The complements the history by focusing on non-invasive bedside assessments to evaluate the extent and acuity of pallor. Inspection targets the skin, palms, nail beds, oral mucosa, and conjunctivae for pallor severity. To assess conjunctival pallor effectively, particularly in suspected anemia, the lower eyelid is gently everted to examine the palpebral conjunctiva on its inner surface; pallor in this area is a recognized clinical sign of anemia, reflecting low hemoglobin levels and reduced oxygenation. Paler mucous membranes often indicate more significant hemoglobin reduction. A red or inflamed eyelid is not a typical sign of anemia; it more commonly suggests alternative conditions such as blepharitis, stye, allergic reaction, or infection. Vital signs are checked for tachycardia, hypotension (e.g., systolic blood pressure below 90 mmHg signaling shock), and tachypnea, which reflect compensatory mechanisms in hypoperfusion states. Palpation evaluates peripheral pulses for strength and symmetry, skin temperature for coolness in shock, and capillary refill time (prolonged beyond 2 seconds suggesting poor perfusion); additional maneuvers include assessing jugular venous pressure and lung sounds for signs of heart failure. These techniques, integrated with history findings, help prioritize urgent interventions without relying on laboratory confirmation. Red flags during evaluation demand immediate attention to avert life-threatening complications. Sudden pallor with retrosternal or diaphoresis may indicate or , warranting rapid stabilization. Similarly, acute pallor accompanied by severe , distension, or guarding suggests internal hemorrhage, such as from or ruptured viscus, necessitating emergent imaging or surgical consultation.

Laboratory and Imaging Tests

Laboratory evaluation of pallor begins with a (CBC), which measures and levels to confirm as a potential cause, with low values indicating reduced oxygen-carrying capacity leading to paleness. A peripheral blood smear is then performed to assess morphology, identifying abnormalities such as microcytosis in or macrocytosis in or deficiencies. Iron studies, including serum , , and , help differentiate from other types, while serum and levels are essential for classifying megaloblastic anemias. For suspected bleeding disorders contributing to pallor through chronic blood loss, a coagulation panel including (PT) and (PTT) evaluates clotting factor function, with prolonged times suggesting deficiencies that may lead to . gas (ABG) analysis assesses oxygenation status, revealing in cases of circulatory compromise where poor causes pallor despite normal levels. Imaging studies target circulatory and hypoperfusion etiologies. Echocardiography evaluates cardiac structure and function, identifying conditions like heart failure that impair systemic perfusion and result in pallor. Computed tomography (CT) angiography detects vascular occlusions, such as arterial emboli, which can cause acute limb pallor due to ischemia. Doppler ultrasound measures peripheral blood flow velocity and direction, confirming reduced perfusion in extremities from peripheral artery disease. Advanced diagnostic procedures are reserved for refractory cases. Bone marrow biopsy is indicated for suspected , revealing hypocellularity that explains severe, non-responsive pallor from bone marrow failure. Upper and lower identifies gastrointestinal bleeding sources, such as ulcers or , which can lead to manifesting as pallor. These tests collectively confirm underlying hematological or circulatory causes of pallor, such as , without overlapping with historical or physical assessments.

Management

Treatment of Underlying Causes

The treatment of pallor primarily involves targeted interventions to address its underlying etiologies, aiming to improve tissue and oxygenation. For hematological causes like , therapy is tailored to the deficiency type. is managed with oral iron supplementation as first-line treatment, typically at doses of 150-200 mg elemental iron daily, while severe cases or those with poor oral absorption may require intravenous iron or transfusions to rapidly restore levels. anemia responds to replacement therapy, often starting with intramuscular injections (1,000 mcg daily for 1 week, then weekly for 4 weeks), transitioning to oral or intranasal forms for maintenance, which corrects the megaloblastic changes and pallor within weeks to months. anemia is treated with oral folic acid supplementation, typically 1-5 mg daily, alongside dietary improvements rich in leafy greens and fortified foods. For anemias due to disorders such as myelodysplastic syndromes, management includes supportive measures like transfusions for symptomatic , erythropoiesis-stimulating agents for eligible low-risk patients, and disease-specific therapies such as hypomethylating agents (e.g., ) or transplantation for higher-risk cases. In chronic kidney disease-related anemia, erythropoiesis-stimulating agents such as recombinant human are administered subcutaneously or intravenously to boost production, targeting levels of 10-11 g/dL to alleviate symptoms including pallor. Circulatory and hypoperfusion causes, such as shock, demand urgent etiology-specific measures to stabilize . from hemorrhage is treated with aggressive fluid using crystalloid solutions or products to expand volume, supplemented by vasopressors like norepinephrine if persists, and surgical intervention (e.g., ligation or repair) to halt . requires immediate broad-spectrum intravenous antibiotics (e.g., plus piperacillin-tazobactam) within the first hour of recognition, combined with source control such as drainage of abscesses, to combat infection and reverse . For chronic circulatory issues like peripheral , revascularization via endovascular procedures such as with or without stenting improves limb and reduces ischemic pallor, while antiplatelet therapy with low-dose aspirin (75-325 mg daily) or clopidogrel prevents progression of . Other causes of pallor necessitate supportive etiology-directed approaches. Emotional pallor, often linked to vasovagal syncope triggered by stress or emotional upset, is managed through non-pharmacological strategies including patient education on trigger avoidance, physical counter-maneuvers (e.g., leg crossing), and counterpressure exercises to maintain venous return and prevent episodes. Hypothermia-induced pallor is addressed by passive rewarming methods, such as removing wet clothing and applying warm blankets to the trunk, or active external rewarming with forced-air devices for moderate cases, aiming to raise core temperature gradually at 0.5-2°C per hour. Hypothyroidism-related pallor improves with lifelong oral levothyroxine replacement therapy, dosed at 1.6 mcg/kg daily and adjusted based on TSH levels, to normalize thyroid function and metabolic rate.

Supportive Care

Supportive care for pallor focuses on stabilizing the patient and improving tissue perfusion while the underlying cause is addressed, often involving non-invasive measures to enhance oxygenation and circulation. In cases where pallor results from hypoxic states, such as those associated with respiratory distress or circulatory compromise, supplemental is administered via or mask to increase and alleviate tissue hypoxia. This approach helps restore color to the skin and mucous membranes by ensuring adequate oxygen delivery to peripheral tissues. To counteract and support hemodynamic stability, particularly in , patients may receive warming with blankets to prevent and promote . Positioning strategies, such as the modified —elevating the legs while keeping the trunk flat—can enhance venous return and cerebral perfusion without risking complications like increased . Continuous monitoring of , including , , and , is essential to detect changes in and guide interventions. provides real-time assessment of oxygen levels, allowing for timely adjustments to therapy and tracking of improvements in pallor. For mild cases of pallor linked to nutritional deficiencies, emphasizes dietary modifications, such as incorporating iron-rich foods like lean meats, leafy greens, and fortified cereals, alongside sources to enhance absorption. Advice may also include avoiding cold exposure to prevent episodic in susceptible individuals. Pallor typically resolves with effective treatment of the underlying condition, restoring normal tone within days to weeks depending on the severity. Persistent pallor despite interventions often signals ongoing severe , warranting further .

References

  1. https://medlineplus.gov/ency/article/003244.htm
  2. https://my.clevelandclinic.org/health/diseases/pallor
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC1497067/
  4. https://www.mayoclinic.org/diseases-conditions/low-blood-pressure/symptoms-causes/syc-20355465
  5. https://www.mayoclinic.org/diseases-conditions/myelodysplastic-syndrome/symptoms-causes/syc-20366977
  6. https://accesspediatrics.mhmedical.com/content.aspx?bookid=842&sectionid=48931830
  7. https://www.medicalnewstoday.com/articles/325562
  8. https://www.sciencedirect.com/topics/medicine-and-dentistry/pallor
  9. https://mycarpe.com/blogs/sweatopedia/what-causes-skin-pallor-and-diaphoresis
  10. https://www.merriam-webster.com/dictionary/pallor
  11. https://www.webmd.com/skin-problems-and-treatments/what-to-know-about-pallor-and-your-health
  12. https://www.cambridge.org/core/books/cambridge-world-history-of-human-disease/anemia/0FF6764286A5B187FF5C984591B487B4
  13. https://uen.pressbooks.pub/anatomyphysiology/chapter/skin-pigment/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC3465481/
  15. https://med.libretexts.org/Bookshelves/Anatomy_and_Physiology/Anatomy_and_Physiology_%28Boundless%29/5%253A_Integumentary_System/5.1%253A_The_Skin/5.1D%253A_Skin_Color
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC4593810/
  17. https://www.sciencedirect.com/topics/immunology-and-microbiology/skin-blood-vessel
  18. https://www.ncbi.nlm.nih.gov/books/NBK596716/
  19. https://www.rch.org.au/rchcpg/hospital_clinical_guideline_index/Neurovascular_observations/
  20. https://www.ncbi.nlm.nih.gov/books/NBK593199/
  21. https://www.hawaii.edu/medicine/pediatrics/pedtext/s11c01.html
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC2797134/
  23. https://my.clevelandclinic.org/health/symptoms/17855-pallor
  24. https://www.sciencedirect.com/topics/medicine-and-dentistry/cold-clammy-skin
  25. https://pressbooks.library.torontomu.ca/assessmentnursing2/chapter/skin-inspection/
  26. https://iu.pressbooks.pub/colorawarenessiudpt/chapter/chapter-3-cardiopulmonary-practice-patterns/
  27. https://www.mountsinai.org/health-library/symptoms/paleness
  28. https://www.merckmanuals.com/professional/critical-care-medicine/shock-and-fluid-resuscitation/shock
  29. https://medlineplus.gov/ency/article/000167.htm
  30. https://www.mayoclinic.org/diseases-conditions/raynauds-disease/symptoms-causes/syc-20363571
  31. https://www.ncbi.nlm.nih.gov/books/NBK499833/
  32. https://publications.aap.org/books/chapter-pdf/779365/aap_9781581109689-part01-ch41.pdf
  33. https://www.ncbi.nlm.nih.gov/books/NBK499994/
  34. https://www.ncbi.nlm.nih.gov/books/NBK448065/
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC5333734/
  36. https://pubmed.ncbi.nlm.nih.gov/37536353/
  37. https://www.ncbi.nlm.nih.gov/books/NBK563146/
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC10699409/
  39. https://www.ncbi.nlm.nih.gov/books/NBK531492/
  40. https://www.ncbi.nlm.nih.gov/books/NBK482255/
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC6246868/
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC5349719/
  43. https://www.ncbi.nlm.nih.gov/books/NBK557482/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC6326052/
  45. https://www.ncbi.nlm.nih.gov/books/NBK513297/
  46. https://pubmed.ncbi.nlm.nih.gov/622960/
  47. https://www.ahajournals.org/doi/10.1161/circulationaha.112.138396
  48. https://www.ncbi.nlm.nih.gov/books/NBK545239/
  49. https://www.mayoclinic.org/diseases-conditions/frostbite/symptoms-causes/syc-20372656
  50. https://pmc.ncbi.nlm.nih.gov/articles/PMC4917788/
  51. https://www.ncbi.nlm.nih.gov/books/NBK519536/
  52. https://www.mayoclinic.org/diseases-conditions/diabetic-hypoglycemia/symptoms-causes/syc-20371525
  53. https://emedicine.medscape.com/article/198475-clinical
  54. https://my.clevelandclinic.org/health/diseases/3929-anemia
  55. https://www.merckmanuals.com/professional/hematology-and-oncology/approach-to-the-patient-with-anemia/evaluation-of-anemia
  56. https://www.merckmanuals.com/professional/hematology-and-oncology/coagulation-disorders/overview-of-coagulation-disorders
  57. https://www.ncbi.nlm.nih.gov/books/NBK536919/
  58. https://www.aafp.org/pubs/afp/issues/2012/0615/p1161.html
  59. https://my.clevelandclinic.org/health/diseases/23491-acute-arterial-occlusion
  60. https://www.mayoclinic.org/tests-procedures/ultrasound/expert-answers/doppler-ultrasound/faq-20058452
  61. https://www.ncbi.nlm.nih.gov/books/NBK534212/
  62. https://www.aafp.org/pubs/afp/issues/2020/0215/p206.html
  63. https://www.mayoclinic.org/diseases-conditions/iron-deficiency-anemia/diagnosis-treatment/drc-20355040
  64. https://www.nhlbi.nih.gov/health/anemia/iron-deficiency-anemia
  65. https://www.mayoclinic.org/diseases-conditions/vitamin-deficiency-anemia/diagnosis-treatment/drc-20355031
  66. https://www.nhlbi.nih.gov/health/anemia/vitamin-b12-deficiency-anemia
  67. https://www.aafp.org/pubs/afp/issues/2017/0915/p384.html
  68. https://www.ncbi.nlm.nih.gov/books/NBK535377/
  69. https://www.cancer.org/cancer/types/myelodysplastic-syndrome/treating/supportive-therapy.html
  70. https://www.niddk.nih.gov/health-information/kidney-disease/anemia
  71. https://pmc.ncbi.nlm.nih.gov/articles/PMC2769266/
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC7139065/
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC4581522/
  74. https://pmc.ncbi.nlm.nih.gov/articles/PMC4504240/
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC7593982/
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC2998831/
  77. https://www.mayoclinic.org/diseases-conditions/hypothermia/diagnosis-treatment/drc-20352688
  78. https://www.cdc.gov/winter-weather/prevention/index.html
  79. https://www.mayoclinic.org/diseases-conditions/hypothyroidism/diagnosis-treatment/drc-20350289
  80. https://pmc.ncbi.nlm.nih.gov/articles/PMC8905334/
  81. https://journals.lww.com/jpcr/fulltext/2020/07060/understanding_facts_about_oxygen_therapy.15.aspx
  82. https://www.myamericannurse.com/how-to-recognize-and-respond-to-hypovolemic-shock/
  83. https://nurseslabs.com/hypovolemic-shock-nursing-care-plans/
  84. https://www.nursetogether.com/anemia-nursing-diagnosis-care-plan/
  85. https://www.healthline.com/health/best-diet-plan-for-anemia
Add your contribution
Related Hubs
User Avatar
No comments yet.